Jonathan Swoboda PhD U.S. FDA

Dr. Jonathan Swoboda works for the FDA in CBER’s Office of Compliance and Biologics Quality as a Consumer Safety Officer. He drafts Warning Letters and Untitled Letters and is a Center Recall Coordinator for non-blood products since 2022. He joined the FDA in late 2011 and has served as a Commissioner’s Fellow in the Center for Biologics Research and Evaluation in addition to a Primary Assessor in the areas of Facilities and Microbiology while performing Pre-Approval Inspections as a Microbiology Subject Matter Expert. In addition to performing application assessments, he has played crucial roles in training other assessors in these disciplines through mentoring, site visits and unique training platforms enabling easy access to up-to-date policies. Prior to joining the FDA, Dr. Swoboda completed a Post-Doctoral Fellowship in regenerative medicine at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation in San Diego. His research focused on the development of high-throughput screening methodologies for identifying regenerative small molecules for the treatment of diabetes, cardiovascular disease and macular degeneration. Dr. Swoboda earned his Ph.D. and MA in Chemistry from Harvard University performing research on innovative antimicrobial therapeutics targeting drug-resistant microorganisms and his B.Sc. in Biochemistry from Brown University.